Review: taking Vyvanse and Ativan together


Summary

Drug interactions are reported among people who take Vyvanse and Ativan together. This review analyzes the effectiveness and drug interactions between Vyvanse and Ativan. It is created by eHealthMe based on reports of 195 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 12,816 users)

Ativan

Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. (latest outcomes from Ativan 46,005 users)

On Sep, 16, 2016

195 people who take Vyvanse, Ativan are studied.


Number of reports submitted per year:

Vyvanse and Ativan drug interactions.

Drug effectiveness over time:

Vyvanse:
  • < 1 month: 71.0% - (5 of 7 people)
  • 1 - 6 months: 33.0% - (3 of 9 people)
  • 6 - 12 months: 42.0% - (3 of 7 people)
  • 1 - 2 years: 60.0% - (6 of 10 people)
  • 2 - 5 years: 57.0% - (4 of 7 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Ativan:
  • < 1 month: 30.0% - (3 of 10 people)
  • 1 - 6 months: 12.0% - (1 of 8 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 77.0% - (7 of 9 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Vyvanse:
  • female: 59.0% - (22 of 37 people)
  • male: 16.0% - (1 of 6 people)
Ativan:
  • female: 48.0% - (17 of 35 people)
  • male: 42.0% - (3 of 7 people)

Drug effectiveness by age:

Vyvanse:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 66.0% - (2 of 3 people)
  • 20-29: 75.0% - (9 of 12 people)
  • 30-39: 30.0% - (4 of 13 people)
  • 40-49: 70.0% - (7 of 10 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 0.0% - (0 of 1 people)
Ativan:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 40.0% - (4 of 10 people)
  • 30-39: 42.0% - (6 of 14 people)
  • 40-49: 60.0% - (6 of 10 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • drug effect decreased
  • drug ineffective
  • therapeutic response unexpected
  • chills
  • drug dependence
  • drug effect increased
  • drug withdrawal syndrome
  • hyperhidrosis
  • influenza
  • pain
1 - 6 months:
  • itching - vaginal area
  • vulvovaginal burning sensation
  • depression
  • dizziness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • feeling jittery
  • frequent headaches
  • heart rate increased
  • intermenstrual bleeding
  • irritability
6 - 12 months:
  • weight gain
  • blue vision
  • csf pressure increased
  • sleeping difficulty
  • anger
  • asthma
  • bone and joint pain
  • bronchitis
  • chest x-ray abnormal
  • depression
1 - 2 years:
  • weight gain
  • anxiety
  • apathy
  • attention deficit hyperactivity disorder
  • hypomania
  • memory impairment
  • photophobia
  • tremor
  • dyskinesia
  • fatigue
2 - 5 years:
  • itching - vaginal area
  • vulvovaginal burning sensation
  • anxiety
  • apathy
  • attention deficit hyperactivity disorder
  • hypomania
  • memory impairment
  • palpitations
  • photophobia
  • tremor
5 - 10 years:
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • pregnancy test false positive
  • short-term memory loss
10+ years:
  • anxiety disorder
  • body dysmorphic disorder
  • body temperature fluctuation
  • borderline personality disorder
  • confusion
  • drug-induced tremor
  • fatigue aggravated
  • fever
  • frequent headaches
  • insomnia exacerbated
not specified:
  • drug ineffective
  • anxiety
  • depression
  • pain
  • abdominal pain
  • arthralgia
  • drug effect decreased
  • nausea
  • weight decreased
  • constipation

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • depression
  • drug ineffective
  • abdominal pain
  • itching - vaginal area
  • vulvovaginal burning sensation
  • arthralgia
  • heart rate increased
  • hyperhidrosis
male:
  • drug effect decreased
  • drug dependence
  • drug effect increased
  • therapeutic response unexpected
  • weight decreased
  • nausea
  • drug ineffective
  • insomnia
  • somnolence
  • activities of daily living impaired

Most common drug interactions by age *:

2-9:
  • hypocalcaemia
  • hypokalaemia
  • apathy
  • asthenia
  • blood creatine phosphokinase increased
  • brain stem glioma
  • depressed level of consciousness
  • drug ineffective
  • dyspnoea
  • dysstasia
10-19:
  • hypercoagulation
  • pulmonary embolism
  • withdrawal bleed
  • pleural effusion
  • vulvovaginal candidiasis
  • abdominal pain
  • alcohol use
  • anxiety
  • atelectasis
  • dyspnoea
20-29:
  • anxiety
  • apathy
  • attention deficit hyperactivity disorder
  • hypomania
  • memory impairment
  • photophobia
  • tremor
  • depersonalisation
  • derealisation
  • drug ineffective
30-39:
  • arthralgia
  • depression
  • pain in extremity
  • abdominal distension
  • abnormal behaviour
  • anger
  • asthma
  • back pain
  • blister
  • bronchitis
40-49:
  • drug effect decreased
  • depression
  • weight increased
  • drug dependence
  • drug effect increased
  • therapeutic response unexpected
  • weight decreased
  • nausea
  • anxiety
  • fatigue
50-59:
  • drug effect decreased
  • drug ineffective
  • anxiety
  • chills
  • drug withdrawal syndrome
  • hyperhidrosis
  • influenza
  • pain
  • palpitations
  • tic
60+:
  • itching - vaginal area
  • vulvovaginal burning sensation
  • constipation
  • abdominal pain
  • chronic obstructive pulmonary disease
  • eructation
  • herpes zoster
  • pain
  • pancreatic neoplasm
  • arthralgia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vyvanse and Ativan?

Can you answer these questions?

More questions for: Vyvanse, Ativan

You may be interested in these reviews

More reviews for: Vyvanse, Ativan

On eHealthMe, Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Ativan (lorazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.